Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE KING : revenue, balance sheet and financial ratios

PHARMACIE KING is a French company founded 6 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in NEUILLY-SUR-MARNE (93330), this company of category PME shows in 2025 a net income negative of -51 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE KING (SIREN 850312380)
Indicator 2025 2024 2023 2022 2021 2020
Revenue N/C N/C N/C N/C N/C N/C
Net income -50 770 € -11 832 € 55 284 € 118 132 € 69 230 € 39 509 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE KING records a net loss of 51 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-50 770 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 223%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

223.222%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

25.315%

Solvency indicators evolution
PHARMACIE KING

Sector positioning

Debt ratio
223.22 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average +24 pts over 3 years

In 2025, the debt ratio of PHARMACIE KING (223.22) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
25.32% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch -26 pts over 3 years

In 2025, the financial autonomy of PHARMACIE KING (25.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of PHARMACIE KING in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE KING with other companies in the same sector:

Frequently asked questions about PHARMACIE KING

What is the revenue of PHARMACIE KING ?

The revenue of PHARMACIE KING is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE KING profitable?

PHARMACIE KING recorded a net loss in 2025.

Where is the headquarters of PHARMACIE KING ?

The headquarters of PHARMACIE KING is located in NEUILLY-SUR-MARNE (93330), in the department Seine-Saint-Denis.

Where to find the tax return of PHARMACIE KING ?

The tax return of PHARMACIE KING is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE KING operate?

PHARMACIE KING operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.